Journal article
A longitudinal study of the SF-36 version 2 in Friedreich ataxia
G Tai, LA Corben, EM Yiu, MB Delatycki
Acta Neurologica Scandinavica | WILEY | Published : 2017
DOI: 10.1111/ane.12693
Abstract
Objectives: The Medical Outcomes Study 36 item Short-Form Health Survey (SF-36) is one of the most commonly used patient reported outcome measure. This study aimed to examine the relationship between SF-36 version 2 (SF-36V2) summary scores and Friedreich ataxia (FRDA) clinical characteristics, and to investigate the responsiveness of the scale, in comparison with the Friedreich Ataxia Rating Scale (FARS), over 1, 2 and 3 years. Materials and Methods: Descriptive statistics were used to examine the characteristics of the cohort at baseline and years 1, 2 and 3. Correlations between FRDA clinical characteristics and SF-36V2 summary scores were reported. Responsiveness was measured using paire..
View full abstractGrants
Funding Acknowledgements
Funding was from the Friedreich Ataxia Research Association (Australasia) and the Friedreich Ataxia Research Alliance (USA). EMY is supported by a National Health Medical Research Council (NHMRC) Early Career Fellowship. MBD receives grant support from NHMRC. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.